American Association for Cancer Research

American Association for Cancer Research
Name	American Association for Cancer Research
Abbreviation	AACR
Formation	1907
Type	Professional association
Headquarters	Philadelphia, Pennsylvania
Region served	International
Membership	Researchers, clinicians, educators
Leader title	President

American Association for Cancer Research is a professional organization dedicated to advancing the study, prevention, diagnosis, and treatment of cancer through research, collaboration, and dissemination of scientific knowledge. Founded in 1907, it brings together investigators from biomedical institutions, pharmaceutical companies, academic centers, and clinical settings to accelerate discovery and translate findings into clinical practice. The association supports basic, translational, clinical, and population science, partnering with academic societies, regulatory bodies, philanthropic foundations, and patient advocacy organizations.

History

The association was established in the early 20th century by clinicians and scientists influenced by contemporaries at institutions such as Johns Hopkins Hospital, Massachusetts General Hospital, Memorial Sloan Kettering Cancer Center, Rockefeller Institute for Medical Research, and Dana-Farber Cancer Institute. Early meetings featured speakers affiliated with National Institutes of Health, Harvard Medical School, Columbia University, University of Pennsylvania, and Yale School of Medicine, reflecting the growth of cancer laboratories at centers like Fred Hutchinson Cancer Center and Sloan Kettering Institute. Over decades the organization expanded alongside milestones at National Cancer Institute, the passage of national initiatives linked to presidents linked with health policy such as the National Cancer Act, and collaborations with societies including American Society of Clinical Oncology, European Society for Medical Oncology, International Union Against Cancer, and World Health Organization. Leadership cycles included presidents drawn from institutions such as University of California, San Francisco, Stanford University School of Medicine, University of Texas MD Anderson Cancer Center, and University of Chicago, reflecting a trajectory from pathology-focused work to molecular oncology, immunotherapy, and precision medicine.

Mission and Objectives

The association’s mission emphasizes accelerating the prevention, diagnosis, and treatment of cancer through research and education. Objectives include promoting basic research at laboratories connected to Cold Spring Harbor Laboratory and Broad Institute, advancing translational pipelines practiced at Mayo Clinic and Cleveland Clinic, supporting clinical trials moderated by Food and Drug Administration pathways and cooperative groups like Eastern Cooperative Oncology Group and SWOG Cancer Research Network, and fostering global partnerships with organizations such as Bill & Melinda Gates Foundation and World Cancer Research Fund. The organization endorses standards influenced by regulatory frameworks from European Medicines Agency and professional guidance from American Medical Association and Institute of Medicine.

Membership and Governance

Membership comprises investigators, clinicians, trainees, laboratory personnel, and industry scientists associated with centers including University of Michigan, Johns Hopkins University, University of Pennsylvania, Columbia University, and University of California, Los Angeles. Governance rests with a board of directors and elected officers drawn from academic units like Harvard Medical School and research nonprofits such as Howard Hughes Medical Institute, with advisory committees formed alongside representatives from American Society for Biochemistry and Molecular Biology and Association of American Medical Colleges. Committees oversee ethics, finance, awards, and publications, with awardees historically including scientists affiliated with Nobel Prize-winning institutions and recipients of honors like the Lasker Award and Gairdner Foundation International Award.

Research and Publications

The association publishes peer-reviewed journals that disseminate advances in molecular oncology, translational research, and clinical trials, contributing to literature alongside titles from Nature Publishing Group, Cell Press, Elsevier, and Wiley-Blackwell. Editorial leadership often includes editors from University of California, San Diego, University of Texas Southwestern Medical Center, and University of Washington. The organization supports research funding mechanisms, grants, fellowships, and career development awards akin to programs at American Cancer Society and Ludwig Institute for Cancer Research, and promotes data-sharing practices interoperable with repositories such as Gene Expression Omnibus and consortia like The Cancer Genome Atlas and International Cancer Genome Consortium.

Meetings and Conferences

Annual meetings convene investigators, clinicians, industry representatives, and policymakers in venues comparable to those used by Association of American Physicians and Federation of American Societies for Experimental Biology, featuring plenary sessions, symposia, and poster presentations. The program highlights themes in immuno-oncology pioneered at places like Dana-Farber Cancer Institute and Memorial Sloan Kettering Cancer Center, precision oncology exemplified by Broad Institute collaborations, and population studies linked to American Institute for Cancer Research. Satellite meetings and workshops are held in partnership with regional bodies such as European Society for Medical Oncology and international partners like Asian Pacific Organization for Cancer Prevention.

Education and Training Programs

The association offers training initiatives for students, postdoctoral fellows, and clinical trainees modeled after programs at Cold Spring Harbor Laboratory and Howard Hughes Medical Institute, including mentorship, career development, and grant-writing workshops. Programs connect trainees with networks at institutions such as Stanford University, Massachusetts Institute of Technology, Cornell University, and University of Toronto, and provide travel awards, fellowships, and coursework that mirror curricula at Harvard T.H. Chan School of Public Health and Johns Hopkins Bloomberg School of Public Health. Collaborations extend to professional development efforts with organizations like Society for Immunotherapy of Cancer and American Association of Immunologists.

Advocacy and Public Policy

The association engages in advocacy to influence research funding, regulatory science, and public health priorities, coordinating with agencies and groups such as National Institutes of Health, National Cancer Institute, Food and Drug Administration, Congressional Biomedical Research Caucus, and philanthropic partners like American Cancer Society. Policy efforts address clinical trial design, drug approval frameworks discussed with European Medicines Agency, and global disparities tackled alongside World Health Organization and Pan American Health Organization. The organization issues position statements, partners on consensus guidelines with American Society of Clinical Oncology, and contributes expert testimony to legislative and regulatory bodies associated with U.S. health policy and international research agendas.

Category:Cancer research organizations